Another study in 2006 focusing on premenopausal women with sexual dysfunction reported that SHBG levels were up to four times higher in OCP users than in those who had never used them and that SHBG levels remained elevated even after discontinuation [16]. The gene discussed is SHBG; the disease is sexual dysfunction.